OzmoCAP® capsules control the release of drug as it transits the gastro-intestinal (GI) tract, and now our customers can visualize this in dogs with matched x-ray imaging and PK sampling. FreeThink quickly develops OzmoCAP® capsules for studies in animals including a...
FreeThink participated in the AAPS Northeast Regional Discussion Group (NERDG) Annual Meeting, which was held in Queens, NY on March 31st. In addition to sponsoring the event, FreeThink exhibited and presented its latest technologies and innovations. Technology...
OzmoCAP® was present at this year’s AAPS PharmSci 360 annual meeting, both in the booth and on the stage. Technology Development Lead Jennifer Chu, Ph.D., gave a presentation on the OzmoCAP® technology titled “Rapid Preclinical Assessment for Extended Release Drug...
